Home / News / Pearce IP Blog
Date: 19 November 2021Court: Full Court of the Federal Court of AustraliaJudges: Middleton, Perram and Nicholas JJ...
Date: 18 November 2021Court: Federal Court of AustraliaJudge: Burley J Background In December 2016 Pfizer Ireland...
The speed of getting a case to trial is a key metric of any litigation system. Pharmaceutical patent litigation often...
09 Nov 21 | Coherus BioSciences reported its Q3 2021 financial results. Coherus announced that FDA review of CHS-201...
01 Nov 21 | The International Generic and Biosimilar Medicines Association called on all stakeholders ahead of its...
In the last year, two significant Federal Court decisions, reported here and here have exposed key flaws in the...
22 Oct 21 | Biocon released its Q2 2022 financial results, reporting a 10% increase in biosimilars revenue year on...
14 Oct 21 | Gan & Lee Pharmaceuticals announced the completion of two Ph III studies of its proposed insulin...
Originally published in World Intellectual Property Review 3 2021 After surviving the Great Patent Cliff of 2011–2016,...
The evolution of jurisprudence in Australia can have far reaching implications for legal practitioners in every...
05 Oct 21 | EU | Celltrion announced that it has submitted a Marketing Authorisation Application to the EMA seeking...
Date: 20 May 2021 / 18 October 2021Court: Federal Court of AustraliaJudge: Greenwood J Background Australian Patent...
27 Sep 21 | CA | Apobiologix announced that Health Canada has approved Bambevi® (biosimilar bevacizumab) in...
Recently, Merck Sharp & Dohme (MSD) (known as Merck & Co., Inc. in the US and Canada) announced a settlement...
27 Sep 21 | Hikma Pharmaceuticals announced that it will acquire Custopharm for an initial cash consideration of USD...
Date: 30 September 2021Court: Federal Court of AustraliaJudge: Rofe J Background The patentee (Surefoot) alleged that...